Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria J Merino

Showing results (281-290 of 296) with videos related to

Pageof 30
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic ResponseFatima Karzai, Stephanie M Walker, Scott Wilkinson, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, David VanderWeele, Ravi A Madan, et al.
International Journal of Cancer|November 15, 2012
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studiesMark P Purdue, Lee E Moore, Maria J Merino, et al.
Clinical Genitourinary Cancer|October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
AJR. American Journal of Roentgenology|July 16, 2025
Evaluating Artificial Intelligence-Assisted Prostate Biparametric MRI Interpretation: An International Multireader StudyDavid G Gelikman, Enis C Yilmaz, Stephanie A Harmon, et al.
European Urology|March 31, 2021
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal TherapyScott Wilkinson, Huihui Ye, Fatima Karzai, et al.
Plos Genetics|September 9, 2011
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5Daphne W Bell, Nilabja Sikdar, Kyoo-Young Lee, et al.
The Lancet. Oncology|July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trialAndrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
Pageof 30

Showing results (281-290 of 296) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 7, 2020
Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is Predictive of Therapeutic ResponseFatima Karzai, Stephanie M Walker, Scott Wilkinson, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutationsFatima Karzai, David VanderWeele, Ravi A Madan, et al.
International Journal of Cancer|November 15, 2012
An investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studiesMark P Purdue, Lee E Moore, Maria J Merino, et al.
Clinical Genitourinary Cancer|October 6, 2018
Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.
Science Signaling|January 6, 2021
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancerDaniel R Crooks, Nunziata Maio, Martin Lang, et al.
The American Journal of Pathology|February 13, 2002
Evaluation of non-formalin tissue fixation for molecular profiling studiesJohn W Gillespie, Carolyn J M Best, Verena E Bichsel, et al.
AJR. American Journal of Roentgenology|July 16, 2025
Evaluating Artificial Intelligence-Assisted Prostate Biparametric MRI Interpretation: An International Multireader StudyDavid G Gelikman, Enis C Yilmaz, Stephanie A Harmon, et al.
European Urology|March 31, 2021
Nascent Prostate Cancer Heterogeneity Drives Evolution and Resistance to Intense Hormonal TherapyScott Wilkinson, Huihui Ye, Fatima Karzai, et al.
Plos Genetics|September 9, 2011
Predisposition to cancer caused by genetic and functional defects of mammalian Atad5Daphne W Bell, Nilabja Sikdar, Kyoo-Young Lee, et al.
The Lancet. Oncology|July 10, 2020
Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trialAndrea B Apolo, Rosa Nadal, Yusuke Tomita, et al.
Pageof 30